Compare FTK & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTK | RXST |
|---|---|---|
| Founded | 1985 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 445.8M | 524.6M |
| IPO Year | N/A | 2021 |
| Metric | FTK | RXST |
|---|---|---|
| Price | $16.15 | $12.30 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 11 |
| Target Price | ★ $16.00 | $11.30 |
| AVG Volume (30 Days) | 318.3K | ★ 876.6K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 242.12 | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $220,501,000.00 | $142,085,000.00 |
| Revenue This Year | $20.33 | N/A |
| Revenue Next Year | $12.59 | $4.18 |
| P/E Ratio | $17.09 | ★ N/A |
| Revenue Growth | ★ 23.56 | 10.75 |
| 52 Week Low | $6.05 | $6.32 |
| 52 Week High | $18.96 | $38.64 |
| Indicator | FTK | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 61.25 |
| Support Level | $15.01 | $12.07 |
| Resistance Level | $16.98 | $13.14 |
| Average True Range (ATR) | 0.83 | 0.66 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 82.33 | 55.03 |
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.